2.4 Eligibility criteria
Patients in this study should meet the following criteria: Pathological diagnosis of NSCLC stage III/IV; One or more two-dimensional measurable lesions; 18 < age < 80; Karnofsky performance status (KPS) score ≥ 60 or Zubrod-ECOG-WHO (ZPS) score ≤ 2; Average life expectancy ≥3 months; normal heart, bone marrow, lung, liver and kidney function.